Physician profile
William Lasswell
NPI 1093898546
$3,767.58
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,153 · 2020: $603 · 2021: $939 · 2022: $652 · 2023: $386 · 2024: $34.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $420.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $795.12 | 2019-2023 | |
| Novo Nordisk INC | $552.12 | 2019-2023 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $456.79 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $431.91 | 2019-2021 | |
| Lilly USA, LLC | $308.83 | 2019-2023 | Jardiance, Lyumjev, Baqsimi |
| Bayer Healthcare Pharmaceuticals INC. | $288.61 | 2021-2023 | |
| Abbott Laboratories | $144.55 | 2019-2024 | Freestyle Libre 3 |
| Dexcom, INC. | $102.28 | 2021-2022 | |
| Radius Health, INC. | $94.36 | 2019-2021 | |
| Insulet Corporation | $83.65 | 2019-2022 | |
| Tandem Diabetes Care, INC. | $65.88 | 2022-2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Amgen INC. | $64.95 | 2019 | |
| Medtronic, INC. | $55.92 | 2022-2023 | Minimed 770g |
| Janssen Pharmaceuticals, INC | $55.88 | 2019-2020 | |
| Abbvie INC. | $52.47 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $41.09 | 2019 | |
| Amarin Pharma, INC. | $37.28 | 2019-2020 | |
| Shire North American Group INC | $36.91 | 2019 | |
| Becton, Dickinson and Company | $24.46 | 2019 | |
| Endo Pharmaceuticals INC. | $18.43 | 2022 | |
| Vivus LLC | $16.89 | 2019 | |
| Medtronic Minimed, INC. | $13.33 | 2019 | |
| Clarus Therapeutics INC. | $12.96 | 2021 | |
| Valeritas, INC. | $12.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Lasswell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.